Eli Lilly 2013 Annual Report Download - page 117

Download and view the complete annual report

Please find page 117 of the 2013 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 160

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160

19
Membership and Meetings of the Board and Its Committees
In 2013, each director attended more than 85 percent of the total number of meetings of the Board and the
committees on which he or she serves. In addition, all Board members are expected to attend the annual
meeting of shareholders, and all the directors attended in 2013. Current committee membership and the
number of meetings of the Board and each committee in 2013 are shown in the table below.
Name Board Audit Compensation
Directors and
Corporate
Governance Finance
Public Policy
and
Compliance
Science and
Technology
Mr. Alvarez Member Member Member
Dr. Baicker Member Member Member
Sir Winfried Bischoff Member Member Former Chair
Mr. Eskew Member Chair Member
Mr. Fyrwald Member Chair Member
Dr. Gilman Member Member Former Chair
Mr. Hoover Member Chair Member
Ms. Horn Member Chair Member
Dr. Kaelin Member Member Chair
Dr. Lechleiter Chair
Ms. Marram Lead Director Member Chair
Mr. Oberhelman Member Member Member
Dr. Prendergast Member Member Member
Dr. Runge Member Member Member
Ms. Seifert Member Member Member
Mr. Tai Member Member Member
Number of 2013
Meetings 8 11 7 5 8 8 6
Board Oversight of Compliance and Risk Management
The Board takes an active role in overseeing the company's compliance and enterprise risk management
programs to ensure the company operates with the highest level of integrity and that the company is
appropriately managing both current and potential future areas of risk.
Code of Ethics
The board approves the company's code of ethics, which is set out in:
The Red Book: a comprehensive code of ethical and legal business conduct applicable to all employees
worldwide and to our Board of Directors. The Red Book is reviewed and approved annually by the Board.
Code of Ethical Conduct for Lilly Financial Management: a supplemental code for our CEO and all
members of financial management, in recognition of their unique responsibilities to ensure proper accounting,
financial reporting, internal controls, and financial stewardship.
Both documents are available online at: http://www.lilly.com/about/business-practices/ethics-compliance, or
upon request to the company's corporate secretary.